Evidence map›Paper›PMID 39440049›Full record

ArticleJournal of Cancer2024

A new clinical prognosis model for breast cancer with ADSS as the hub gene.

Zhi Zhang, Fei Xu, Suna Zeng, Xiaoying Li, Yuzhe Cai, Jinghua Li, Zha Peng, Yixuan Chen, Chengyu Huang, Ting Li and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhi ZhangDepartment of Hepatobiliary Surgery, Guangxi Medical University Affliated Wuming Hospital, Nanning 530199, China.
Fei XuExperimental Center of BIOQGene, YuanDong International Academy of Life Sciences, Hong Kong 999077, China.
Suna ZengDepartment of Stomatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xiaoying LiExperimental Center of BIOQGene, YuanDong International Academy of Life Sciences, Hong Kong 999077, China.
Yuzhe CaiThe Graduate School of Guangxi Medical University, Nanning, China.
Jinghua LiDepartment of General Surgery, Guangxi Medical University Affliated Wuming Hospital, Nanning 530199, China.
Zha PengThe Graduate School of Guangxi Medical University, Nanning, China.
Yixuan ChenExperimental Center of BIOQGene, YuanDong International Academy of Life Sciences, Hong Kong 999077, China.
Chengyu HuangExperimental Center of BIOQGene, YuanDong International Academy of Life Sciences, Hong Kong 999077, China.
Ting LiExperimental Center of BIOQGene, YuanDong International Academy of Life Sciences, Hong Kong 999077, China.
Steven MoExperimental Center of BIOQGene, YuanDong International Academy of Life Sciences, Hong Kong 999077, China.
Tongling ZhaoDepartments of Developmental Planning, Guangxi Medical University, Nanning, China.
Hai HuangDepartment of General Surgery, Guangxi Medical University Affliated Wuming Hospital, Nanning 530199, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADSSBRCAclinical indicator modelprognosisWGCNA

Identifiers

PMID39440049
PMCPMC11492999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.